Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Bluejay Diagnostics (NASDAQ: BJDX) announced its participation in the H.C. Wainwright 24th Annual Global Investment Conference, scheduled for September 12-14, 2022, at the Lotte Palace Hotel, New York City. CEO Neil Dey and CFO Kenneth Fisher will present on September 13 at 10:30 AM ET. The management team will also engage in one-on-one meetings with investors. Bluejay focuses on rapid, cost-effective diagnostic testing, with its first candidate, an IL-6 Test for sepsis triage, promising results in about 20 minutes. For further details, visit bluejaydx.com.

ACTON, Mass., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient tests for triage and monitoring of disease progression, today announced that Neil Dey, Chief Executive Officer, and Kenneth Fisher, Chief Financial Officer, will present at the H.C. Wainwright 24^th Annual Global Investment Conference taking place on September 12-14, 2022, at the Lotte Palace Hotel in New York City.

H.C. Wainwright 24^th Annual Global Investment Conference

Date:	Tuesday, September 13, 2022
Time:	10:30 AM ET

The Bluejay management team will also participate in one-on-one meetings during the event. Investors interested in meeting with Bluejay at the conference should contact their H.C. Wainwright representative.

About Bluejay Diagnostics:
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for triage and monitoring of disease progression. Bluejay’s first product candidate, an IL-6 Test for sepsis triage, is designed to provide accurate, reliable results in approximately 20 minutes from ‘sample-to-result’ to help medical professionals make earlier and better triage/treatment decisions. More information is available at www.bluejaydx.com.

Investor Contact:
Alexandra Schuman
LifeSci Advisors
alex@lifesciadvisors.com
t: 646-876-3647

FAQ

When is Bluejay Diagnostics presenting at the H.C. Wainwright conference?

Bluejay Diagnostics will present on September 13, 2022, at 10:30 AM ET.

Who will represent Bluejay Diagnostics at the conference?

CEO Neil Dey and CFO Kenneth Fisher will represent Bluejay Diagnostics.

What is the purpose of Bluejay’s participation in the conference?

Bluejay aims to engage with investors and showcase its diagnostic innovations.

What does Bluejay Diagnostics focus on in the medical field?

Bluejay focuses on developing rapid, near-patient tests for disease triage and monitoring.

What is the significance of Bluejay's IL-6 Test?

The IL-6 Test is designed for sepsis triage, providing results in about 20 minutes.